Aprea Therapeutics, Inc. Contracts & Agreements
44 Contracts & Agreements
- Business Finance (15 contracts)
- Business Operations (5)
- Human Resources (19)
- Mergers & Acquisitions (1)
- Uncategorized (4)
- At the Market Offering Agreement dated as of November 8, 2024, between Aprea Therapeutics, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on November 8, 2024)
- Confidential Severance Agreement and General Release, effective as of October 9, 2024, by and between Aprea Therapeutics, Inc. and Nadeem Q. Mirza, M.D., M.P.H (Filed With SEC on November 7, 2024)
- Aprea Therapeutics, Inc. Inducement Restricted Stock Unit Award Agreement, dated May 1, 2024, by and between Aprea Therapeutics, Inc. and Nadeem Q. Mirza, M.D., M.P.H (Filed With SEC on May 14, 2024)
- Aprea Therapeutics, Inc. Inducement Stock Option Agreement, dated May 1, 2024, by and between Aprea Therapeutics, Inc. and Nadeem Q. Mirza, M.D., M.P.H (Filed With SEC on May 14, 2024)
- Employment Agreement, effective as of May 1, 2024, by and between Aprea Therapeutics, Inc. and Nadeem Q. Mirza, M.D., M.P.H (Filed With SEC on May 14, 2024)
- DESCRIPTION OF REGISTRANTS SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 (Filed With SEC on March 26, 2024)
- Form of Tranche A Warrant (Filed With SEC on March 12, 2024)
- Form of Pre-Funded Warrant (Filed With SEC on March 12, 2024)
- Form of Tranche B Warrant (Filed With SEC on March 12, 2024)
- Form of Securities Purchase Agreement, dated as of March 11, 2024, by and between Aprea Therapeutics, Inc. and the purchasers named therein (Filed With SEC on March 12, 2024)
- Form of Registration Rights Agreement, dated as of March 11, 2024, by and between Aprea Therapeutics and the purchasers (Filed With SEC on March 12, 2024)
- Placement Agency Agreement, dated as of March 11, 2024, by and between Aprea Therapeutics, Inc. and Maxim Group LLC (Filed With SEC on March 12, 2024)
- Separation and General Release Agreement between Aprea Therapeutics, Inc. and Christian S. Schade (Filed With SEC on March 30, 2023)
- Employment Agreement between Aprea Therapeutics, Inc. and John P. Hamill (Filed With SEC on March 30, 2023)
- Employment Agreement between Aprea Therapeutics, Inc. and Oren Gilad (Filed With SEC on March 30, 2023)
- Confidential Severance Agreement and General Release between Aprea Therapeutics, Inc. and Scott M. Coiante (Filed With SEC on March 30, 2023)
- Retention Letter Agreement between Aprea Therapeutics, Inc. and Scott M. Coiante (Filed With SEC on March 30, 2023)
- Separation Agreement and General Release between Aprea Therapeutics, Inc. and Gregory A. Korbel, Ph.D (Filed With SEC on March 30, 2023)
- Retention Letter Agreement between Aprea Therapeutics, Inc. and Gregory A. Korbel, Ph.D (Filed With SEC on March 30, 2023)
- Separation and General Release Agreement between Aprea Therapeutics, Inc. and Lars Abrahmsen (Filed With SEC on March 30, 2023)
- Separation and General Release Agreement between Aprea Therapeutics, Inc. and Eyal Attar (Filed With SEC on March 30, 2023)
- Employment Agreement between Aprea Therapeutics, Inc. and Eyal Attar (Filed With SEC on March 30, 2023)
- DESCRIPTION OF REGISTRANTS SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 (Filed With SEC on March 30, 2023)
- Underwriting Agreement, dated as of February 22, 2023, between Aprea Therapeutics, Inc. and Maxim Group LLC (Filed With SEC on February 24, 2023)
- Form of Registration Rights Agreement, by and among Aprea and certain securityholders (Filed With SEC on May 17, 2022)
- Agreement and Plan of Merger, dated May 16, 2022 by and among Aprea, ATR Merger Sub I Inc., ATR Merger Sub II LLC and Atrin (Filed With SEC on May 17, 2022)
- Description of the Companys Common Stock, $0.001 par value (Filed With SEC on March 16, 2021)
- Companion Diagnostic Agreement dated August 11, 2020, by and between Invivoscribe, Inc. and the Registrant (Filed With SEC on August 11, 2020)
- Description of the Companys Common Stock, $0.001 par value (Filed With SEC on March 27, 2020)
- Form of Executive Employment Agreement (Filed With SEC on September 27, 2019)
- Specimen common stock certificate of the Registrant (Filed With SEC on September 27, 2019)
- Form of 2019 Stock Incentive Plan and form of agreements thereunder (Filed With SEC on September 27, 2019)
- Employment Agreement between the Registrant and Christian S. Schade (Filed With SEC on September 27, 2019)
- Employment Agreement between the Registrant and Lars Abrahmsen, Ph.D (Filed With SEC on September 27, 2019)
- Employment Agreement between the Registrant and Gregory A. Korbel, Ph.D (Filed With SEC on September 27, 2019)
- Employment Agreement between the Registrant and Scott M. Coiante (Filed With SEC on September 27, 2019)
- Master Manufacturing and Supply Agreement, between Aprea Therapeutics AB and Siegfried Hameln GmbH (Filed With SEC on September 25, 2019)
- Form of Amended and Restated Registration Rights Agreement, by and among the Registrant and the shareholders party thereto (Filed With SEC on September 25, 2019)
- Service Agreement, between Aprea AB and Syngene International Private Limited (Filed With SEC on September 25, 2019)
- Form of 2019 Employee Stock Purchase Plan and form of agreements thereunder (Filed With SEC on September 25, 2019)
- Form of 2019 Stock Incentive Plan and form of agreements thereunder (Filed With SEC on September 25, 2019)
- Form of Underwriting Agreement (Filed With SEC on September 23, 2019)
- APREA THERAPEUTICS, INC. DIRECTOR AND OFFICER INDEMNIFICATION AGREEMENT (Filed With SEC on September 23, 2019)
- Service Agreement, between Aprea AB and Syngene International Private Limited (Filed With SEC on September 23, 2019)
